BeStock  
Stocks › Biotechnology › TLX

Telix Pharmaceuticals TLX

US equityMarket cap rank #2480Biotechnology
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership48.2%+1.25 pts vs. prior quarter
Institutions holding152+7 vs. prior quarter
Insider trades (recent)3 buys / 0 sellsNet buying
Short interest0.08% of floatDays to cover 1.0 · as of 30 Oct 2026
Short-sale volume share19.6%5-day average of daily volume

Short-sale volume as % of daily volume

12%19%26%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$222.3K (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$541.2KSuper+$318.9KBig−$967.4KMid−$949.6KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.1% of shares outstanding.

Largest holders

  • JPMorgan Chase & Co.8.96%
  • State Street Global Advisors8.06%
  • Andreas Kluge6.67%
  • Christian Behrenbruch6.43%
  • Challenger Limited4.98%
  • Citigroup Inc.3.35%
  • Grand Pharmaceutical Group Limited3.22%
  • Vanguard Capital Management, LLC3.14%

By investor type

  • Mutual Fund26.45%
  • Public Company15.55%
  • Individual/Insider8.19%
  • Government Pension Fund2.26%
  • VC/PE Fund1.47%
  • Sovereign Wealth Fund1.35%
  • Private Company0.98%
  • Hedge Fund0.13%

Reported short interest has held roughly steady near 0.08% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Dimensional Fund Advisors Mutual Fund 2026/Q3 +1,137,118 0.8%
BetaShares Capital Limited Mutual Fund 2026/Q3 +149,259 0.6%
JPMorgan Chase & Co. Public Company 2026/Q3 +4,167,050 9.0%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +950,408 0.8%
William Blair Investment Management, LLC Mutual Fund 2026/Q3 +357,700 0.1%
Vanguard Investments Australia Limited Mutual Fund 2026/Q3 +188,531 1.9%
Vanguard Asset Management, Limited Mutual Fund 2026/Q3 +180,887 0.3%
BetaShares Capital Limited Mutual Fund 2026/Q3 +123,546 0.6%
Aubrey Capital Management Limited Mutual Fund 2026/Q3 +105,000 0.0%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +100,696 3.1%
Hennion & Walsh Asset Management, Inc. Mutual Fund 2026/Q3 +65,718 0.1%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +871,964 0.8%
Vanguard Asset Management, Limited Mutual Fund 2026/Q3 +66,893 0.2%
Van Eck Associates Corporation Mutual Fund 2026/Q3 +49,637 0.2%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +47,292 3.1%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
6 Sep 2026 Darren Smith Group Chief Financial Officer Private Acquisition +2,071 $9.66 13,992
28 Apr 2026 Christian Behrenbruch Co-Founder, MD, Group CEO & Executive Director Open Market Acquisition +67,935 $14.87 20,996,941
28 Mar 2026 Darren Smith Group Chief Financial Officer Derivative Exercise and Retained +1,111 – 11,921
17 Mar 2026 David Cade Group Chief Medical Officer Initial Statement of Beneficial +0 – 12,566
17 Mar 2026 Darren Smith Group Chief Financial Officer Initial Statement of Beneficial +0 – 15,852
17 Mar 2026 Mark Nelson Independent Non-Executive Director Initial Statement of Beneficial +0 – 3,628,750
17 Mar 2026 Christian Behrenbruch Co-Founder, MD, Group CEO & Executive Director Initial Statement of Beneficial +0 – 2,595
17 Mar 2026 Jann Skinner Independent Non-Executive Director Initial Statement of Beneficial +0 – 595,000
17 Mar 2026 Darren Patti Group Chief Operating Officer Initial Statement of Beneficial +0 – 804

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 270,623 0.1% 1.0
15 Oct 2026 352,936 0.1% 1.1
30 Sep 2026 426,829 0.1% 1.0
15 Sep 2026 352,524 0.1% 1.0
31 Aug 2026 264,943 0.1% 1.8
14 Aug 2026 244,900 0.1% 2.3

Discussion

No comments yet — be the first to weigh in on TLX.

Sign in to join the discussion.

Scroll to Top